Headache

Papers
(The H4-Index of Headache is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma115
Erratum96
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin76
A retrospective analysis of the use of candesartan for migraine prevention in adolescents56
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report55
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space40
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions38
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive37
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine35
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine34
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers31
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine30
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study28
Post‐traumatic headache: An unmet medical need28
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment28
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study28
Migraine screening in English and Spanish27
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA27
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample26
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine26
Migraine and peripheral pain models show differential alterations in neuronal complexity26
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine26
Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 202426
Patient headache questionnaires can improve headache diagnosis and treatment in children26
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study25
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine25
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study25
Index25
0.070195198059082